CINELLI, ELEONORA
 Distribuzione geografica
Continente #
AS - Asia 1.371
NA - Nord America 1.077
EU - Europa 1.066
SA - Sud America 199
AF - Africa 30
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.747
Nazione #
US - Stati Uniti d'America 1.046
SG - Singapore 796
RU - Federazione Russa 635
CN - Cina 213
HK - Hong Kong 172
BR - Brasile 169
IT - Italia 118
VN - Vietnam 90
DE - Germania 87
NL - Olanda 58
IN - India 37
FR - Francia 30
UA - Ucraina 30
FI - Finlandia 22
GB - Regno Unito 20
SE - Svezia 16
MX - Messico 14
CA - Canada 10
KR - Corea 10
PL - Polonia 10
ZA - Sudafrica 10
BG - Bulgaria 9
AR - Argentina 8
BD - Bangladesh 8
ES - Italia 8
TR - Turchia 8
CI - Costa d'Avorio 7
AT - Austria 6
CL - Cile 6
ID - Indonesia 6
IE - Irlanda 5
JP - Giappone 5
AE - Emirati Arabi Uniti 4
EC - Ecuador 4
LT - Lituania 4
VE - Venezuela 4
CO - Colombia 3
MA - Marocco 3
PA - Panama 3
PK - Pakistan 3
PY - Paraguay 3
SN - Senegal 3
AU - Australia 2
DO - Repubblica Dominicana 2
IQ - Iraq 2
IR - Iran 2
JO - Giordania 2
NP - Nepal 2
TH - Thailandia 2
UY - Uruguay 2
AL - Albania 1
BB - Barbados 1
BE - Belgio 1
BH - Bahrain 1
DK - Danimarca 1
DZ - Algeria 1
EU - Europa 1
GA - Gabon 1
GM - Gambi 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
LB - Libano 1
LY - Libia 1
MD - Moldavia 1
ML - Mali 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
RS - Serbia 1
SA - Arabia Saudita 1
SD - Sudan 1
UZ - Uzbekistan 1
Totale 3.747
Città #
Singapore 369
Hong Kong 172
Moscow 162
Chandler 117
Beijing 93
Ashburn 92
Santa Clara 86
Amsterdam 58
Napoli 52
Lawrence 44
Millbury 43
Des Moines 36
Los Angeles 32
Boston 31
Redondo Beach 27
Dallas 21
Hefei 21
Ho Chi Minh City 21
Munich 21
Düsseldorf 20
Hanoi 19
Wilmington 19
Naples 17
Buffalo 15
Turku 14
Frankfurt am Main 13
New York 13
São Paulo 12
Brooklyn 11
Rio de Janeiro 11
Seattle 11
Houston 10
The Dalles 10
Chicago 9
Fairfield 9
Nuremberg 9
Lauterbourg 8
Orem 7
Sofia 7
Stockholm 7
Denver 6
Helsinki 6
Redwood City 6
San Francisco 6
Warsaw 6
Washington 6
Woodbridge 6
Atlanta 5
Bhubaneswar 5
Falkenstein 5
Guangzhou 5
Kochi 5
London 5
Mexico City 5
Montreal 5
Seoul 5
Asciano 4
Biên Hòa 4
Bắc Giang 4
Da Nang 4
Haiphong 4
Johannesburg 4
Milan 4
Phoenix 4
Poplar 4
Santiago 4
Tokyo 4
Afragola 3
Aracaju 3
Asunción 3
Atibaia 3
Brasília 3
Campinas 3
Caracas 3
Chennai 3
Dakar 3
Dublin 3
Esslingen am Neckar 3
Fremont 3
Gangnam-gu 3
Hyderabad 3
Panama City 3
Paris 3
Porto Alegre 3
Pune 3
Quận Bình Thạnh 3
Segrate 3
Shanghai 3
Vinh 3
Amman 2
Andradina 2
Ankara 2
Aparecida de Goiânia 2
Bear 2
Burgas 2
Bình An 2
Calgary 2
Camboriú 2
Cambridge 2
Campo Grande 2
Totale 1.968
Nome #
Therapeutic update of biologics and small molecules for scalp psoriasis: a systematic review 147
Efficacy and safety of risankizumab in psoriasis patients who failed anti‐IL‐17, anti‐12/23 and/or anti IL‐23: preliminary data of a real‐life 16‐week retrospective study 126
Endocrinological disorders and inflammatory skin diseases during COVID-19 outbreak: A review of the literature 126
Erythrasmoid pityriasis versicolor with exclusive involvement of the pubis and inguinal region: report of two cases. 123
A case of a primary cutaneous diffuse large B-cell lymphoma, leg type 116
Apremilast efficacy and safety in elderly psoriasis patients over a 48-weeks period 115
QuantiFERON TB‐gold conversion rate among psoriasis patients under biologics: a 9‐year retrospective study 113
Calcipotriol/betamethasone dipropionate formulations for psoriasis: an overview of the options and efficacy data 109
Erythrodermic psoriasis successfully and rapidly treated with brodalumab: report of two cases 109
Efficacy and safety of ixekizumab in a group of 16 elderly patients with psoriasis over a 1‐year period 102
Biologic Therapies, Psoriasis, and COVID-19: Our Experience at the Psoriasis Unit of the University of Naples Federico II 101
Efficacy and safety of a new topical gel formulation containing retinol encapsulated in glycospheres and hydroxypinacolone retinoate, an antimicrobial peptide, salicylic acid, glycolic acid and niacinamide for the treatment of mild acne: preliminary results of a 2-month prospective study 101
A case of Stewart-Treves Syndrome of the lower limbs: The usefulness of dermoscopy 99
16-year real-life study on the prevalence of mycoses in a paediatric population 99
A 15-year retrospective study on the prevalence of onychomycosis in psoriatic vs non-psoriatic patients: A new European shift from dermatophytes towards yeast. 98
Hereditary Angioedema Type III, Recurrent Pregnancy Loss and Heterozygous MTHFR Mutation 98
Anti‐interleukin‐23 for psoriasis in elderly: guselkumab, risankizumab and tildrakizumab in real world practice 94
Leg paralysis after photodynamic therapy for Lymphomatoid Papulosis: a case report 92
Tinea Capitis in Campania: A 5-Year Retrospective Study in Childhood and Adolescence (2013-2018). 89
Risankizumab in real life: preliminary results of efficacy and safety in psoriasis during a 16-week period 89
Teledermatology for patient management, dermatology education and research during the COVID-19 pandemic 88
Efficacy and safety of guselkumab in psoriasis patients who failed ustekinumab and/or anti IL-17: a real-life 52-week retrospective study 88
Real life efficacy and safety of secukinumab in elderly psoriasis patients over a 2-year period 87
Mycoses in the elderly population: what a 16-year experience has taught us 86
A Case of Steatocystoma Multiplex in a Psoriatic Patient during Treatment with Anti-IL-12/23 86
Paracetamol-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) in a psoriasis patient receiving apremilast therapy 83
Occurrence of psoriasiform eruption during dupilumab therapy for adult atopic dermatitis: A case series 81
Tildrakizumab: a new therapeutic option for erythrodermic psoriasis? 80
A case of erythrodermic psoriasis successfully treated with apremilast 78
Dermoscopy and reflectance confocal microscopy of Kaposi's sarcoma: an overview 77
Hedgehog inhibitors in the treatment of advanced basal cell carcinoma: risks and benefits 71
Trends in epidemiology of melanoma in situ in a center of South-Italy: Data from a melanoma reference center during the period 2004–2018 69
Chronic cutaneous ulcers management in dermatologic department during COVID-19 era 67
Safe distance, safe patients! Therapeutic management of oncological patients affected by cutaneous and mucosal adverse events during the COVID-19 pandemic: an Italian experience 65
Treatment of pediatric psoriasis with TNF-antagonists: a real-life single-center case series 62
Retrospective analysis of skin toxicity in patients under anti-EGFR tyrosine kinase inhibitors: Our experience in lung cancer 58
Guselkumab in moderate to severe psoriasis in routine clinical care: an Italian 44-week real-life experience 56
Guselkumab and risankizumab for psoriasis: a 44-week indirect real-life comparison 54
Micro needling: A novel therapeutic approach for androgenetic alopecia, A Review of Literature 52
Real world practice indirect comparison between guselkumab and risankizumab: results from an Italian retrospective study 51
Dietary Intervention: An Essential Part of the Management of Patients Affected by Hidradenitis Suppurativa 49
Psoriasis awareness among general population: preliminary results of an online survey 47
Ocular Manifestations in Psoriasis Screening (OcMaPS) Questionnaire: A Useful Tool to Reveal Misdiagnosed Ocular Involvement in Psoriasis 46
Profile of baricitinib and its potential in the treatment of moderate to severe atopic dermatitis: A short review on the emerging clinical evidence 42
Ixekizumab in scalp psoriasis: Clinical, dermoscopical, and in vivo reflectance confocal microscopy evaluation 38
Real-world experience versus clinical trials: pros and cons in psoriasis therapy evaluation 34
Totale 3.841
Categoria #
all - tutte 13.553
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.553


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021128 0 0 0 0 0 13 5 57 4 28 18 3
2021/2022258 9 4 0 11 15 9 2 8 3 41 44 112
2022/2023301 46 30 12 11 34 31 0 18 37 55 22 5
2023/2024209 9 35 20 20 12 25 3 18 2 4 44 17
2024/20251.452 55 84 3 5 45 77 133 99 108 236 490 117
2025/20261.386 264 142 263 193 438 86 0 0 0 0 0 0
Totale 3.841